Skip to main content

Advertisement

Log in

ASO Author Reflections: Surgical Management Should be Considered in Patients with De Novo Stage IV Inflammatory Breast Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Khan SA, Zhao F, Goldstein LJ, et al. Early local therapy for the primary site in De Novo Stage IV breast cancer: results of a randomized clinical trial (EA2108). J Clin Oncol Official J Am Soc Clin Oncol. JCO2102006 (2022). https://doi.org/10.1200/JCO.21.02006

  2. Khan SA. Does resection of an intact breast primary improve survival in metastatic breast cancer? Oncology (Williston Park). 2007;21(8):924–31; Discussion 931-2, 934, 942, passim.

  3. Menta A, Fouad TM, Lucci A, et al. Inflammatory breast cancer: What to know about this unique, aggressive breast cancer. Surg Clin North Am. 2018;98(4):787–800. https://doi.org/10.1016/j.suc.2018.03.009.

    Article  PubMed  Google Scholar 

  4. Chen JC, Li Y, Fisher JL, et al. Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11975-6.

  5. Akay CL, Ueno NT, Chisholm GB, et al. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Cancer. 2014;120(9):1319–28. https://doi.org/10.1002/cncr.28550.

    Article  PubMed  Google Scholar 

Download references

Funding

Samilia Obeng-Gyasi is funded by the Paul Calabresi Career Development Award (K12 CA133250)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samilia Obeng-Gyasi MD, MPH.

Ethics declarations

Disclosure

The authors declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, J.C., Bazan, J.G. & Obeng-Gyasi, S. ASO Author Reflections: Surgical Management Should be Considered in Patients with De Novo Stage IV Inflammatory Breast Cancer. Ann Surg Oncol 29, 6689–6690 (2022). https://doi.org/10.1245/s10434-022-12016-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12016-y

Navigation